Adamek RJ et al. |
Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection. |
1995 |
Am. J. Gastroenterol. |
pmid:7801936
|
Jaup BH and Norrby A |
Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. |
1995 |
Am. J. Gastroenterol. |
pmid:7771426
|
Gisbert JP et al. |
Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment? |
2005 |
Am. J. Gastroenterol. |
pmid:16128936
|
Pamuk ON et al. |
Are Turkish Helicobacter pylori strains gaining resistance against clarithromycin? |
2000 |
Am. J. Gastroenterol. |
pmid:10926000
|
Sontag SJ et al. |
Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin. |
2001 |
Am. J. Gastroenterol. |
pmid:11374672
|
Laine L et al. |
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial. |
2003 |
Am. J. Gastroenterol. |
pmid:12650788
|
Schaeverbeke T et al. |
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study. |
2005 |
Am. J. Gastroenterol. |
pmid:16393213
|
al-Assi MT et al. |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. |
1994 |
Am. J. Gastroenterol. |
pmid:8053435
|
de Bortoli N et al. |
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. |
2007 |
Am. J. Gastroenterol. |
pmid:17313499
|
Mohar A et al. |
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure. |
2002 |
Am. J. Gastroenterol. |
pmid:12385434
|
De Francesco V et al. |
Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia? |
2002 |
Am. J. Gastroenterol. |
pmid:12385470
|
Chey WD and Wong BC |
American College of Gastroenterology guideline on the management of Helicobacter pylori infection. |
2007 |
Am. J. Gastroenterol. |
pmid:17608775
|
Savarino V et al. |
What is the meaning of ranitidine in successful triple-therapy against Helicobacter pylori infection? |
1995 |
Am. J. Gastroenterol. |
pmid:8540537
|
Gisbert JP et al. |
Response to article by Forné et al. |
1996 |
Am. J. Gastroenterol. |
pmid:8561132
|
Uygun A et al. |
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population. |
1999 |
Am. J. Gastroenterol. |
pmid:10520880
|
Cremonini F et al. |
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. |
2002 |
Am. J. Gastroenterol. |
pmid:12425542
|
Peterson WL et al. |
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. |
1993 |
Am. J. Gastroenterol. |
pmid:8237933
|
Nista EC et al. |
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. |
2006 |
Am. J. Gastroenterol. |
pmid:16968503
|
van Zanten SV and Thompson K |
Should the presence of polymorphisms of CYP2C19 enzymes influence the choice of the proton pump inhibitor for treatment of Helicobacter pylori infection? |
2006 |
Am. J. Gastroenterol. |
pmid:16863548
|
Froehlich F et al. |
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. |
2001 |
Am. J. Gastroenterol. |
pmid:11513170
|
Rokkas T et al. |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment. |
2006 |
Am. J. Gastroenterol. |
pmid:16928256
|
Sugimoto M et al. |
Prevention of hemorrhage from intradiverticular ulcer in the duodenum by Helicobacter pylori eradication. |
2000 |
Am. J. Gastroenterol. |
pmid:10685780
|
Coelho LG et al. |
Once-daily Helicobacter pylori treatment to family members of gastric cancer patients. |
2000 |
Am. J. Gastroenterol. |
pmid:10710099
|
Pilotto A et al. |
In vitro activity of rifabutin against strains of Helicobacter pylori resistant to metronidazole and clarithromycin. |
2000 |
Am. J. Gastroenterol. |
pmid:10710100
|
Hansen JM et al. |
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study. |
2008 |
Am. J. Gastroenterol. |
pmid:18445098
|
Vakil N |
H. pylori treatment: new wine in old bottles? |
2009 |
Am. J. Gastroenterol. |
pmid:19098845
|
Watson JB and Moss SF |
Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen. |
2011 |
Am. J. Gastroenterol. |
pmid:22056576
|
Rokkas T et al. |
Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen. |
2009 |
Am. J. Gastroenterol. |
pmid:19098844
|
Lazzaroni M et al. |
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer. |
1997 |
Am. J. Gastroenterol. |
pmid:9128316
|
Sapone A et al. |
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management. |
2003 |
Am. J. Gastroenterol. |
pmid:12809821
|
van der Hulst RW et al. |
Therapeutic options after failed Helicobacter pylori eradication therapy. |
1996 |
Am. J. Gastroenterol. |
pmid:8931413
|
Alder JD et al. |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies. |
1996 |
Am. J. Gastroenterol. |
pmid:8931416
|
Zhou L et al. |
A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. |
2014 |
Am. J. Gastroenterol. |
pmid:24642580
|
Sharma VK et al. |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection. |
1999 |
Am. J. Gastroenterol. |
pmid:10566709
|
Levy M et al. |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. |
2002 |
Am. J. Gastroenterol. |
pmid:11866264
|
Christopher K et al. |
Clarithromycin use preceding fulminant hepatic failure. |
2002 |
Am. J. Gastroenterol. |
pmid:11866297
|
Gisbert JP et al. |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. |
2006 |
Am. J. Gastroenterol. |
pmid:16454825
|
Stack WA et al. |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. |
1998 |
Am. J. Gastroenterol. |
pmid:9772054
|
Adamek RJ and Bethke TD |
Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group. |
1998 |
Am. J. Gastroenterol. |
pmid:9772056
|
Ali' A et al. |
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment. |
1999 |
Am. J. Gastroenterol. |
pmid:10445583
|
Vakil N et al. |
Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. |
1998 |
Am. J. Gastroenterol. |
pmid:9732920
|
Chu KM et al. |
A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori. |
1998 |
Am. J. Gastroenterol. |
pmid:9732921
|
Fennerty MB |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance. |
1998 |
Am. J. Gastroenterol. |
pmid:9448162
|
Lamouliatte H et al. |
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study. |
1998 |
Am. J. Gastroenterol. |
pmid:9732938
|
Forné M et al. |
Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing. |
1998 |
Am. J. Gastroenterol. |
pmid:9448170
|
Hsu PI et al. |
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. |
2005 |
Am. J. Gastroenterol. |
pmid:16279889
|
Vakil N |
Helicobacter pylori: factors affecting eradication and recurrence. |
2005 |
Am. J. Gastroenterol. |
pmid:16279890
|
Sullivan B et al. |
Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. |
2002 |
Am. J. Gastroenterol. |
pmid:12385435
|
Chiba N |
Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. |
1996 |
Am. J. Gastroenterol. |
pmid:8855737
|
Labenz J and Börsch G |
Toward an optimal treatment of Helicobacter pylori-positive peptic ulcers. |
1995 |
Am. J. Gastroenterol. |
pmid:7733070
|
Gisbert JP et al. |
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. |
2008 |
Am. J. Gastroenterol. |
pmid:17764498
|
Forné M et al. |
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study. |
1995 |
Am. J. Gastroenterol. |
pmid:7733075
|
Dohil R et al. |
Effective 2-wk therapy for Helicobacter pylori disease in children. |
1997 |
Am. J. Gastroenterol. |
pmid:9040199
|
Lerang F et al. |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? |
1997 |
Am. J. Gastroenterol. |
pmid:9040200
|
Odaka T et al. |
Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. |
2002 |
Am. J. Gastroenterol. |
pmid:11922552
|
Chey WD et al. |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. |
1997 |
Am. J. Gastroenterol. |
pmid:9317068
|
Giannini E et al. |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. |
2000 |
Am. J. Gastroenterol. |
pmid:11051345
|
Vakil N and Cutler A |
Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori. |
1999 |
Am. J. Gastroenterol. |
pmid:10235192
|
Scholte GH et al. |
Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy. |
2002 |
Am. J. Gastroenterol. |
pmid:12135019
|
Gatta L et al. |
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. |
2009 |
Am. J. Gastroenterol. |
pmid:19844205
|
Ozmen MM and Johnson CD |
Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication? |
1995 |
Am. J. Gastroenterol. |
pmid:7661197
|
Kim CG et al. |
Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial. |
2008 |
Am. J. Gastroenterol. |
pmid:17714557
|
Savarino V et al. |
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. |
1995 |
Am. J. Gastroenterol. |
pmid:7717343
|
Trevisani L et al. |
A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. |
1998 |
Am. J. Gastroenterol. |
pmid:9517646
|
Zullo A et al. |
Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study. |
1997 |
Am. J. Gastroenterol. |
pmid:9362185
|
Kawasaki M et al. |
Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. |
1997 |
Am. J. Gastroenterol. |
pmid:9382064
|
Adamek RJ et al. |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection. |
1997 |
Am. J. Gastroenterol. |
pmid:9382084
|
Sirimontaporn N et al. |
Ten-day sequential therapy of Helicobacter pylori infection in Thailand. |
2010 |
Am. J. Gastroenterol. |
pmid:20010919
|
Basu PP et al. |
A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. |
2011 |
Am. J. Gastroenterol. |
pmid:21989146
|
Laine L et al. |
Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. |
1998 |
Am. J. Gastroenterol. |
pmid:9820381
|
Moayyedi P and Malfertheiner P |
Editorial: Sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn? |
2009 |
Am. J. Gastroenterol. |
pmid:19956122
|
Zullo A et al. |
A quintuple therapy for H. pylori eradication. |
2007 |
Am. J. Gastroenterol. |
pmid:17958765
|
Hasegawa T et al. |
Image of the month: Disseminated Nontuberculous Mycobacteriosis. |
2015 |
Am. J. Gastroenterol. |
pmid:26673493
|
Schwartz H et al. |
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. |
1998 |
Am. J. Gastroenterol. |
pmid:9576452
|
de Boer WA et al. |
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9672338
|
Calvet X et al. |
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial. |
2005 |
Am. J. Gastroenterol. |
pmid:16086704
|
Park CS et al. |
Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance. |
2014 |
Am. J. Gastroenterol. |
pmid:25091062
|
Vakil N and Fennerty MB |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. |
1996 |
Am. J. Gastroenterol. |
pmid:8607487
|
Treiber G |
The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. |
1996 |
Am. J. Gastroenterol. |
pmid:8607488
|
Shaheen N and Grimm IS |
Fulminant hepatic failure associated with clarithromycin. |
1996 |
Am. J. Gastroenterol. |
pmid:8607519
|
Bardhan KD et al. |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. |
1998 |
Am. J. Gastroenterol. |
pmid:9517644
|
Adamek RJ et al. |
Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome. |
1998 |
Am. J. Gastroenterol. |
pmid:9517645
|
Vakil N |
Helicobacter pylori treatment: a practical approach. |
2006 |
Am. J. Gastroenterol. |
pmid:16542285
|
Santander C et al. |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. |
1996 |
Am. J. Gastroenterol. |
pmid:8759659
|
Tursi A et al. |
Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication. |
1996 |
Am. J. Gastroenterol. |
pmid:8759696
|
Jarbol DE et al. |
Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial. |
2006 |
Am. J. Gastroenterol. |
pmid:16771937
|
Bytzer P |
Management of the dyspeptic patient: anything goes? |
2006 |
Am. J. Gastroenterol. |
pmid:16771938
|
Manes G et al. |
Eradication of Helicobacter pylori and dosages of esomeprazole. |
2006 |
Am. J. Gastroenterol. |
pmid:16771971
|
Fuccio L et al. |
Can sequential therapy for Helicobacter pylori eradication overcome clarithromycin resistance?: Data still do not support conclusions. |
2010 |
Am. J. Gastroenterol. |
pmid:20606668
|
van der Wouden EJ et al. |
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. |
1998 |
Am. J. Gastroenterol. |
pmid:9707042
|
Laine L et al. |
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. |
2000 |
Am. J. Gastroenterol. |
pmid:11151867
|
Laine L et al. |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. |
1999 |
Am. J. Gastroenterol. |
pmid:10201465
|
Nakao K et al. |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. |
1997 |
Am. J. Gastroenterol. |
pmid:9177520
|
Maconi G et al. |
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? |
2001 |
Am. J. Gastroenterol. |
pmid:11232676
|
Parasakthi N and Goh KL |
Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia. |
1995 |
Am. J. Gastroenterol. |
pmid:7872306
|
Laine L et al. |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. |
1997 |
Am. J. Gastroenterol. |
pmid:9399755
|
Srinivasan R and Minocha A |
Cure of Helicobacter pylori: a hidden curse? |
1997 |
Am. J. Gastroenterol. |
pmid:9399784
|
Nam SY et al. |
Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. |
2010 |
Am. J. Gastroenterol. |
pmid:20571493
|
Luther J et al. |
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability. |
2010 |
Am. J. Gastroenterol. |
pmid:19755966
|
Chey WD et al. |
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. |
2017 |
Am. J. Gastroenterol. |
pmid:28071659
|